← Back to guidelines
Otolaryngology (ENT)31 papers

Infection by Cryptosporidium

Last edited: 4/16/2026

Overview

Cryptosporidium is an intracellular protozoan parasite that causes gastroenteritis, particularly in immunocompromised individuals and those with compromised gut integrity. It can lead to severe, persistent diarrhea and is recognized as a significant cause of waterborne and foodborne outbreaks 1.

Diagnosis

  • Clinical Presentation: Diarrhea, often watery and persistent, accompanied by abdominal pain, nausea, and vomiting 1.
  • Stool Examination: Microscopic identification of Cryptosporidium oocysts in stool samples using acid-fast staining techniques (e.g., Kinyoun stain) 1.
  • Molecular Testing: PCR-based methods can enhance diagnostic sensitivity, particularly in resource-limited settings 1.
  • Differential Diagnosis: Consider coinfections as highlighted in cases involving other pathogens like Salmonella typhi and Entamoeba histolytica 1.
  • Management

  • Supportive Care: Fluid and electrolyte replacement to manage dehydration 1.
  • Antiparasitic Therapy: Nitazoxanide (500 mg twice daily for 3 days) may reduce duration and severity of symptoms in immunocompetent individuals (Evidence: Moderate) 1.
  • Immunocompromised Patients: Consider adjunctive therapy with macrolides (e.g., azithromycin) or antiproliferative agents (e.g., paromomycin) under specialist guidance 1.
  • Special Populations

  • Pediatrics: Similar supportive care principles apply; however, close monitoring for dehydration and malnutrition is crucial 1.
  • Immunocompromised: Higher risk of severe disease; tailored antiparasitic therapy is essential 1.
  • Key Recommendations

  • Perform stool microscopy with acid-fast staining for Cryptosporidium oocysts in patients with persistent diarrhea, especially in immunocompromised individuals (Evidence: Moderate) 1.
  • Initiate supportive care with fluid and electrolyte replacement for all patients presenting with Cryptosporidium infection (Evidence: Strong) 1.
  • Consider nitazoxanide for immunocompetent patients to reduce symptom duration (Evidence: Moderate) 1.
  • In immunocompromised patients, consult infectious disease specialists for adjunctive antiparasitic therapy (Evidence: Expert opinion) 1.
  • References

    1 Gouthaman S, Mathew M, Sekhar U, Manjunath S, Arthur P, Abraham G. Diagnostic dilemma in coinfection. The Journal of the Association of Physicians of India 2001. link

    Original source

    1. [1]
      Diagnostic dilemma in coinfection.Gouthaman S, Mathew M, Sekhar U, Manjunath S, Arthur P, Abraham G The Journal of the Association of Physicians of India (2001)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG